CC Yang, YW Tsai, SH Wang, JY Wu, TH Liu… - Frontiers in …, 2024 - frontiersin.org
Background: The effectiveness of the novel oral antiviral agents, nirmatrelvir plus ritonavir
and molnupiravir, in treating COVID-19 in patients with nonalcoholic fatty liver disease is …